Individualised Transcranial Magnetic Stimulation (TMS) is a non-invasive therapy using electromagnetic stimulation of the brain. The magnetic field produced by the procedure induces trace amounts of electrical current in the brain. It is used after diagnosis for treatment and has shown great promise in the treatment of certain conditions or disorders that are not responsive to conventional treatments.
The procedure is administered by placing a special coil over the head while the patient remains seated in a chair. A powerful, painless, magnetic field is pulsed into the brain based on a specific treatment protocol. Each session takes approximately 19 minutes. Patients are thoroughly screened and evaluated before the treatment and are monitored during TMS treatment session by a trained and TMS technician or other certified clinician or practitioner to minimize any risk from the procedure, to monitor the patient’s response to treatment, and to monitor proper for continued treatment coil contact.
There is no guarantee that patients will respond positively to this therapy and as with all therapies, there is a chance of injury. However, transcranial magnetic stimulation is Therapeutic Goods Agency (TGA)-approved for specific conditions, such as major depressive disorder in adult patients, and other conditions depending on the TMS system being used for treatment. The results of research and clinical trials have shown improvement and positive results in patients suffering from various neuropsychiatric disorders including anxiety, attention deficit disorder, autistic spectrum disorder, mild and moderate traumatic brain injury, substance abuse, and other psychiatric and neurological conditions.
In certain circumstances seizures have been shown to occur. This average risk is believed to be 1 in 30,000 treatments.
About ten percent (10%) of patients undergoing this procedure will experience headaches and/or scalp discomfort at the treatment site that may last several hours following the treatment. Some patients may experience facial twitching, fatigue and lighheadedness. Some patients experience exacerbation or recurrence of previous symptoms during the early phase of treatment. Side effects generally subside after the first few treatment sessions.